Ludwig Cancer Research

Ludwig Cancer Research
Founded1971
FounderDaniel K. Ludwig
HeadquartersNew York, NY, USA;
Zürich, Switzerland
Region served
International
FieldsCancer research
Key people
Chi Van Dang, MD, PhD
(LICR CEO and Scientific Director); Jonathan Skipper, PhD (LICR President)
Websitewww.ludwigcancerresearch.org

Ludwig Cancer Research is an international network of research institutes and laboratories that conduct basic, translational, and clinical studies on cancer. The name refers collectively to two distinct components: the Ludwig Institute for Cancer Research (LICR), an international non-profit organization founded in 1971 by American businessman and philanthropist Daniel K. Ludwig, and the six endowed and independent Ludwig Centers established in 2006 at prominent U.S. biomedical research institutions.

Ludwig Cancer Research supports fundamental and translational cancer research in cancer immunology, genomics, cancer metabolism, metastasis, epigenetics and the tumor microenvironment, with the goal of developing novel diagnostics and therapies. Its global structure seeks to foster collaboration to advance the understanding of cancer biology and the application of that knowledge to its prevention, diagnosis, and treatment.